IP Verse

Merz Pharma competitive analysis

Latest publications and patents of Merz Pharma New

Explore the latest publications and patents granted to Merz Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Merz Pharma
EP4161562	Nov 20, 2024	High Dose And Low Volume Botulinum Toxin Treatment Of Facial Wrinkles	Granted And Under Opposition
EP3236939	Aug 28, 2024	Botulinum Toxin Prefilled Container	Patent Maintained As Amended
EP3125961	Jul 31, 2019	Polysaccharide Soft Tissue Fillers With Improved Persistence	Opposition Rejected
EP2836196	Jun 12, 2019	Preparation For Topical Application To Mucosa Containing Polyhexanide As Active Ingredient	Revoked
EP2627318	Aug 16, 2017	Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian Excipients	Opposition Rejected
EP2723319	Mar 29, 2017	Composition Comprising An Onion Extract And Liposomes	Opposition Rejected

Latest oppositions filed by Merz Pharma

Explore patent oppositions filed by Merz Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3796929	Suppression Of Bone Cancer-Induced Allodynia	IPSEN BIOPHARM	Jun 18, 2025
EP3509559	Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof	ALLERGAN PHARMACEUTICALS	Mar 7, 2024
EP3256097	Compositions And Methods For Improving Skin Appearance	ALLERGAN INDUSTRIE	Oct 5, 2022
EP2649101	Process Of Preparing A Cross Linked Gel	TEOXANE	Mar 2, 2022
EP3279335	Highly Sensitive Cell-Based Assay To Detect The Presence Of Active Botulinum Neurotoxin Serotype-A	ABEL	Dec 8, 2021
EP3138586	Soft Tissue Filler	ALLERGAN INDUSTRIE	Oct 6, 2021
EP3270951	Botulinum Neurotoxin-Specific Capture Agents, Compositions, And Methods Of Using And Making	CALIFORNIA INSTITUTE OF TECHNOLOGY	Jun 9, 2021
EP3270162	Botulinum Toxin Assay With Improved Sensitivity	BIOMADISON	Mar 30, 2021
EP3187219	Injection Device	ALLERGAN	Jan 22, 2021
EP2674147	Hyaluronic Acid-Based Gels Including Anesthetic Agents	ALLERGAN INDUSTRIE	Sep 30, 2020

Latest patents of Merz Pharma opposed by its competitors

Explore Merz Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP4161562	Nov 20, 2024	High Dose And Low Volume Botulinum Toxin Treatment Of Facial Wrinkles	1
EP3236939	Aug 28, 2024	Botulinum Toxin Prefilled Container	1
EP3125961	Jul 31, 2019	Polysaccharide Soft Tissue Fillers With Improved Persistence	1
EP2836196	Jun 12, 2019	Preparation For Topical Application To Mucosa Containing Polyhexanide As Active Ingredient	1
EP2627318	Aug 16, 2017	Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian Excipients	1
EP2723319	Mar 29, 2017	Composition Comprising An Onion Extract And Liposomes	1

Latest PTAB cases involving Merz Pharma

Discover the latest PTAB cases involving Merz Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Merz Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
MERZ PHARMA	17	6	-	-	Highly Aggressive
ALLERGAN	11	28	13	33	Balanced
ALLERGAN INDUSTRIE	-	11	-	10	Non-Active
BIOMADISON	-	3	-	-	Non-Active